DLin-MC3-DMA
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
mono-Pal-MTO is a palm oil-based lipid produced by combining the anticancer drug mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they show effective siRNA cell delivery and enhance anticancer activity.
| CAS No. | Not available |
| Chemical Name | mono-Pal-MTO |
| Synonyms | monoPalMTO, mono Pal MTO |
| SMILES | CCCCCC/C=C\CCCCCCCC(OCCNCCNC1=C2C(C(C3=C(O)C=CC(O)=C3C2=O)=O)=C(C=C1)NCCNCCO)=O |
| Formula | C38H56N4O7 |
| M.Wt | 680.87 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 14.6871 mL | 2.9374 mL | 1.4687 mL |
| 25 mg | 36.7177 mL | 7.3435 mL | 3.6718 mL |
| 50 mg | 73.4355 mL | 14.6871 mL | 7.3435 mL |
| 100 mg | 146.8709 mL | 29.3742 mL | 14.6871 mL |
| 250 mg | 367.1773 mL | 73.4355 mL | 36.7177 mL |
Contact our team with the catalog number and requested quantity.